Cargando…
Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
Glioma is one of the most typical intracranial tumors, comprising about 80% of all brain malignancies. Several key molecular signatures have emerged as prognostic biomarkers, which indicate room for improvement in the current approach to glioma classification. In order to construct a more veracious...
Autores principales: | Lin, Shaojian, Xu, Houshi, Zhang, Anke, Ni, Yunjia, Xu, Yuanzhi, Meng, Tong, Wang, Mingjie, Lou, Meiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571468/ https://www.ncbi.nlm.nih.gov/pubmed/33123464 http://dx.doi.org/10.3389/fonc.2020.541401 |
Ejemplares similares
-
Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future
por: Zhu, Zhengyang, et al.
Publicado: (2022) -
Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17
por: Zhang, Anke, et al.
Publicado: (2021) -
Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi‐center study
por: Zhang, Anke, et al.
Publicado: (2021) -
An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas
por: Xu, Yang, et al.
Publicado: (2020) -
URB2 as an important marker for glioma prognosis and immunotherapy
por: Fang, Chaoyou, et al.
Publicado: (2023)